INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "COMBINATION OF USP48 INHIBITORS AND DNMT1 INHIBITORS FOR USE IN CANCER THERAPY"

GENEVA, May 12 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215-5450) filed a patent application (PCT/US2025/052878) for "COMBINATION OF USP48 INHIBITORS AND DNMT1 INHIBITORS FOR USE IN CANCER THERAPY" on Oct 28, 2025. With publication no. WO/2026/096487, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STEGMAIER, Kimberly (c/o Dana-Farber Cancer Institute, Inc.450 Brookline AvenueBoston, Massachusetts 02215-5450), ALEXE, Gabriela (c/o Dana-Farber Cancer Institute, Inc.450 Brookline Av...